Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hossein Rahimi

Showing results (91-100 of 96) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 96 results.
Blood|May 5, 2009
Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL)Ghada Kchour, Mahdi Tarhini, Mohamad-Mehdi Kooshyar, et al.
Current Therapeutic Research, Clinical and Experimental|January 17, 2022
A Post-Marketing Surveillance Study to Evaluate the Safety Profile of Alvotere<sup>Ⓡ</sup> (Docetaxel) in Iranian Patients Diagnosed with Different Types of Cancers Receiving ChemotherapyFarhad Shahi, Farahnaz Vafaeezadeh, Nafiseh Ansarinejad, et al.
Retrovirology|August 22, 2013
The combination of arsenic, interferon-alpha, and zidovudine restores an "immunocompetent-like" cytokine expression profile in patients with adult T-cell leukemia lymphomaGhada Kchour, Rahim Rezaee, Reza Farid, et al.
Nanomedicine (London, England)|March 8, 2021
Nanotechnology against the novel coronavirus (severe acute respiratory syndrome coronavirus 2): diagnosis, treatment, therapy and future perspectivesHamid Rashidzadeh, Hossein Danafar, Hossein Rahimi, et al.
Tanaffos|November 4, 2015
Approach to Patients with Severe Asthma: a Consensus Statement from the Respiratory Care Experts' Input Forum (RC-EIF), IranKhalil Ansarin, Davood Attaran, Hamidreza Jamaati, et al.
International Immunopharmacology|February 14, 2021
Efficacy and safety of convalescent plasma therapy in severe COVID-19 patients with acute respiratory distress syndromeAbolghasem Allahyari, Mohsen Seddigh-Shamsi, Mahmoud Mahmoudi, et al.
Pageof 10

Showing results (91-100 of 96) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 96 results.
Blood|May 5, 2009
Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL)Ghada Kchour, Mahdi Tarhini, Mohamad-Mehdi Kooshyar, et al.
Current Therapeutic Research, Clinical and Experimental|January 17, 2022
A Post-Marketing Surveillance Study to Evaluate the Safety Profile of Alvotere<sup>Ⓡ</sup> (Docetaxel) in Iranian Patients Diagnosed with Different Types of Cancers Receiving ChemotherapyFarhad Shahi, Farahnaz Vafaeezadeh, Nafiseh Ansarinejad, et al.
Retrovirology|August 22, 2013
The combination of arsenic, interferon-alpha, and zidovudine restores an "immunocompetent-like" cytokine expression profile in patients with adult T-cell leukemia lymphomaGhada Kchour, Rahim Rezaee, Reza Farid, et al.
Nanomedicine (London, England)|March 8, 2021
Nanotechnology against the novel coronavirus (severe acute respiratory syndrome coronavirus 2): diagnosis, treatment, therapy and future perspectivesHamid Rashidzadeh, Hossein Danafar, Hossein Rahimi, et al.
Tanaffos|November 4, 2015
Approach to Patients with Severe Asthma: a Consensus Statement from the Respiratory Care Experts' Input Forum (RC-EIF), IranKhalil Ansarin, Davood Attaran, Hamidreza Jamaati, et al.
International Immunopharmacology|February 14, 2021
Efficacy and safety of convalescent plasma therapy in severe COVID-19 patients with acute respiratory distress syndromeAbolghasem Allahyari, Mohsen Seddigh-Shamsi, Mahmoud Mahmoudi, et al.
Pageof 10